The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.

BACKGROUND: Health facility stock-outs of artemether-lumefantrine (AL), the common first-line therapy for uncomplicated malaria across Africa, adversely affect effective malaria case-management. They have been previously reported on various scales in time and space, however the magnitude of the prob...

Bibliográfalaš dieđut
Váldodahkkit:	Sudoi, R, Githinji, S, Nyandigisi, A, Muturi, A, Snow, R, Zurovac, D
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	BioMed Central 2012

Geahča maid

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya
Dahkki: Sudoi Raymond K, et al.
Almmustuhtton: (2012-02-01)

Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2008)

Reducing stock-outs of life saving malaria commodities using mobile phone text-messaging: SMS for life study in Kenya
Dahkki: Githinji, S, et al.
Almmustuhtton: (2013)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2008)

The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
Dahkki: Kangwana, B, et al.
Almmustuhtton: (2011)

Introduction of malaria rapid diagnostic tests, new guidelines, and artemether-lumefantrine in Kenya: A cluster randomized trial
Dahkki: Skarbinski, J, et al.
Almmustuhtton: (2007)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
Dahkki: Wasunna, B, et al.
Almmustuhtton: (2008)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
Dahkki: Wasunna, B, et al.
Almmustuhtton: (2008)

The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya.
Dahkki: Gitonga, C, et al.
Almmustuhtton: (2008)

Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial.
Dahkki: Skarbinski, J, et al.
Almmustuhtton: (2009)

Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya.
Dahkki: Nyandigisi, A, et al.
Almmustuhtton: (2011)

Major improvements in the quality of malaria case-management under the "test and treat" policy in Kenya
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2014)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2007)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Dahkki: Ssekitooleko James, et al.
Almmustuhtton: (2008-09-01)

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2005)

Using mobile phone text messaging for malaria surveillance in rural Kenya.
Dahkki: Githinji, S, et al.
Almmustuhtton: (2014)

IMPACT OF SUBSIDIZED ARTEMETHER-LUMEFANTRINE (AL) IN THE RETAIL SECTOR ON COVERAGE OF PROMPT EFFECTIVE TREATMENT OF CHILDREN UNDER FIVE IN KENYA: A CLUSTER RANDOMIZED CONTROLLED TRIAL
Dahkki: Kangwana, B, et al.
Almmustuhtton: (2010)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
Dahkki: Zurovac Dejan, et al.
Almmustuhtton: (2008-02-01)

The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
Dahkki: Beth P Kangwana, et al.
Almmustuhtton: (2011-05-01)

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in children in western Kenya
Dahkki: Akhwale Willis S, et al.
Almmustuhtton: (2008-12-01)

Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
Dahkki: Mugoyela V, et al.
Almmustuhtton: (2011-09-01)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
Dahkki: Sileshi Belew, et al.
Almmustuhtton: (2020-04-01)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Dahkki: Chanda Pascalina, et al.
Almmustuhtton: (2007-03-01)

Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya.
Dahkki: Andrew Nyandigisi, et al.
Almmustuhtton: (2011-01-01)

"Even if you know everything you can forget": health worker perceptions of mobile phone text-messaging to improve malaria case-management in Kenya.
Dahkki: Jones, C, et al.
Almmustuhtton: (2012)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
Dahkki: White, N, et al.
Almmustuhtton: (1999)

Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
Dahkki: Charles O. Obonyo, et al.
Almmustuhtton: (2022-06-01)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.
Dahkki: Sipilanyambe, N, et al.
Almmustuhtton: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
Dahkki: Sipilanyambe, N, et al.
Almmustuhtton: (2008)

The impact of a community awareness strategy on caregiver treatment seeking behaviour and use of artemether-lumefantrine for febrile children in rural Kenya
Dahkki: Wasunna, B, et al.
Almmustuhtton: (2015)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
Dahkki: van Vugt, M, et al.
Almmustuhtton: (2000)

The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya.
Dahkki: Beatrice Wasunna, et al.
Almmustuhtton: (2015-01-01)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
Dahkki: White, N, et al.
Almmustuhtton: (1999)

Major improvements in the quality of malaria case-management under the "test and treat" policy in Kenya.
Dahkki: Dejan Zurovac, et al.
Almmustuhtton: (2014-01-01)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
Dahkki: Ali, S, et al.
Almmustuhtton: (2010)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Dahkki: Tarning Joel, et al.
Almmustuhtton: (2010-10-01)

Ownership and use of mobile phones among health workers, caregivers of sick children and adult patients in Kenya: cross-sectional national survey.
Dahkki: Zurovac, D, et al.
Almmustuhtton: (2013)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
Dahkki: Snow Robert W, et al.
Almmustuhtton: (2008-01-01)